Correlation Between Pfizer and Ardagh

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Ardagh at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Ardagh into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Ardagh Holdings USA, you can compare the effects of market volatilities on Pfizer and Ardagh and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Ardagh. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Ardagh.

Diversification Opportunities for Pfizer and Ardagh

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and Ardagh is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Ardagh Holdings USA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ardagh Holdings USA and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Ardagh. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ardagh Holdings USA has no effect on the direction of Pfizer i.e., Pfizer and Ardagh go up and down completely randomly.

Pair Corralation between Pfizer and Ardagh

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Ardagh. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 7.02 times less risky than Ardagh. The stock trades about -0.23 of its potential returns per unit of risk. The Ardagh Holdings USA is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  6,150  in Ardagh Holdings USA on August 28, 2024 and sell it today you would earn a total of  981.00  from holding Ardagh Holdings USA or generate 15.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy42.86%
ValuesDaily Returns

Pfizer Inc  vs.  Ardagh Holdings USA

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Ardagh Holdings USA 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ardagh Holdings USA are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, Ardagh sustained solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Ardagh Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Ardagh

The main advantage of trading using opposite Pfizer and Ardagh positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Ardagh can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ardagh will offset losses from the drop in Ardagh's long position.
The idea behind Pfizer Inc and Ardagh Holdings USA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets